Literature DB >> 26550273

Lower serum bilirubin concentration in patients with migraine.

Ling Cao1, Li Xue1, De-Mei Luo1.   

Abstract

BACKGROUND: Bilirubin has been seen as a toxic waste product since it is product of heme metabolism. It's the latest in a series of studies showed that the concentration of serum bilirubin is associated with various diseases such as multiple sclerosis, hypertension and cardiovascular diseases (CVD). However, no study to investigate the association between serum bilirubin and migraine, thus, our aim is to investigate the association between serum bilirubin and migraine.
METHODS: Serum samples were collected from 120 patients with migraine and 128 healthy individuals, serum total bilirubin (Tbil), serum direct bilirubin (Dbil) and serum indirect bilirubin (Ibil) concentration were measured to this study.
RESULTS: Tbil, Dbil and Ibil concentration were significantly lower in patients with migraine than healthy controls. Tbil, Dbil and Ibil concentration also were lower in patients with migraine compared with healthy controls when serum bilirubin concentration further was grouped by gender.
CONCLUSIONS: We found evidence that lower serum bilirubin in patients with migraine, serum bilirubin may be useful markers to estimate neurogenic inflammation in patients with migraine.

Entities:  

Keywords:  Serum bilirubin; migraine; neurogenic inflammation

Year:  2015        PMID: 26550273      PMCID: PMC4612958     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  23 in total

1.  Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study.

Authors:  L Djoussé; D Levy; L A Cupples; J C Evans; R B D'Agostino; R C Ellison
Journal:  Am J Cardiol       Date:  2001-05-15       Impact factor: 2.778

2.  Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults.

Authors:  M Madhavan; W A Wattigney; S R Srinivasan; G S Berenson
Journal:  Atherosclerosis       Date:  1997-05       Impact factor: 5.162

3.  Relationship between bilirubin, apolipoprotein B, and coronary artery disease.

Authors:  S S Levinson
Journal:  Ann Clin Lab Sci       Date:  1997 May-Jun       Impact factor: 1.256

Review 4.  C-reactive protein and migraine. Facts or speculations?

Authors:  Giuseppe Lippi; Camilla Mattiuzzi; Gianfranco Cervellin
Journal:  Clin Chem Lab Med       Date:  2014-09       Impact factor: 3.694

Review 5.  Conventional vascular risk factors: their role in the association between migraine and cardiovascular diseases.

Authors:  Simona Sacco; Francesca Pistoia; Diana Degan; Antonio Carolei
Journal:  Cephalalgia       Date:  2014-12-11       Impact factor: 6.292

Review 6.  The epidemiology, burden, and comorbidities of migraine.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Neurol Clin       Date:  2009-05       Impact factor: 3.806

7.  Relationship between serum bilirubin concentration and nondipper hypertension.

Authors:  Mehmet Demir; Canan Demir; Serdar Keçeoğlu
Journal:  Int J Clin Exp Med       Date:  2014-05-15

Review 8.  Migraine, cardiovascular disease, and stroke during pregnancy: systematic review of the literature.

Authors:  Ashley Wabnitz; Cheryl Bushnell
Journal:  Cephalalgia       Date:  2014-10-10       Impact factor: 6.292

9.  Association between serum bilirubin and estimated glomerular filtration rate among elderly persons.

Authors:  Ryuichi Kawamoto; Daisuke Ninomiya; Yoichi Hasegawa; Yoshihisa Kasai; Tomo Kusunoki; Nobuyuki Ohtsuka; Teru Kumagi
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

Review 10.  Epigenetic mechanisms in migraine: a promising avenue?

Authors:  Else Eising; Nicole A Datson; Arn M J M van den Maagdenberg; Michel D Ferrari
Journal:  BMC Med       Date:  2013-02-04       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.